CVRx wins heart failure CE Mark for Barostim Neo neurostim device

CVRx adds CE Mark approval for treating heart failure patients to its European Union approval for hypertension treatment using its Barostim Neo device.

CVRx said today that it won CE Mark approval in the European Union for its Barostim Neo device to treat heart failure patients using vagus nerve stimulation.

CVRx Inc.

News Well, Cardiovascular, CE Mark, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uWIREY